SCHEMBL6821032

SCHEMBL6821032

Clc1nc(NCC2CC2)c2ncn(C3CCCC3)c2n1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.64
ADORA1 P30542 6/20 0.64
ADORA2A P29274 3/20 0.64
CDK1 P06493 3/20 0.63
CCNB2 O95067 1/20 0.63
CCNE2 O96020 1/20 0.63
CDK4 P11802 1/20 0.63
CCNB1 P14635 1/20 0.63
CCND1 P24385 1/20 0.63
CCNE1 P24864 1/20 0.63
CDK2 P24941 1/20 0.63
CCNB3 Q8WWL7 1/20 0.63
ADORA2B P29275 1/20 0.53
NT5E P21589 1/20 0.52
CTSL P07711 4/20 0.51
YTHDC1 Q96MU7 2/20 0.49
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817815 0.96 ADORA3 (0.60) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL6945547 0.94 ADORA3 (0.61) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL6818080 0.86 ADORA3 (0.61) ADORA3ADORA1ADORA2ACDK1CTSL
SCHEMBL6817775 0.84 CTSL (0.59) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL5193703 0.84 ADORA3 (0.53) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL6820586 0.84 YTHDC1 (0.57) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL6820577 0.83 CTSL (0.49) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL6820593 0.82 CTSL (0.66) ADORA3ADORA1ADORA2ACDK1CCNB2
SCHEMBL6817730 0.82 CTSL (0.54) ADORA3ADORA1ADORA2ACDK1ADORA2B
SCHEMBL6820816 0.82 YTHDC1 (0.70) ADORA3ADORA1ADORA2AYTHDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056745-B1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMA INC (US) 2004-06-16 EP disclosed
US-6413974-B1 INHIBITORS OF CYCLIN DEPENDENT KINASES, PARTICULARLY CDK-2; PREVENTING APOPTOSIS IN NEURONAL CELLS; ANTINEOPLASTIC AGENTS; NEURONAL INJURY AND DEGENERATION; CEREBROVASCULAR DISEASE AVENTIS PHARMACEUTICALS INC. 2002-07-02 US disclosed
EP-1056745-A2 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043676-A2 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed